Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.

Hintzsche JD, Yoo M, Kim J, Amato CM, Robinson WA, Tan AC.

BMC Med Genomics. 2018 Apr 20;11(Suppl 2):26. doi: 10.1186/s12920-018-0350-1.

2.

ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.

Couts KL, Bemis J, Turner JA, Bagby SM, Murphy D, Christiansen J, Hintzsche JD, Le A, Pitts TM, Wells K, Applegate A, Amato C, Multani P, Chow-Maneval E, Tentler JJ, Shellman YG, Rioth MJ, Tan AC, Gonzalez R, Medina T, Doebele RC, Robinson WA.

Mol Cancer Ther. 2018 Jan;17(1):222-231. doi: 10.1158/1535-7163.MCT-17-0472. Epub 2017 Oct 20.

3.

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA.

Melanoma Res. 2017 Jun;27(3):189-199. doi: 10.1097/CMR.0000000000000345.

4.

A Survey of Computational Tools to Analyze and Interpret Whole Exome Sequencing Data.

Hintzsche JD, Robinson WA, Tan AC.

Int J Genomics. 2016;2016:7983236. doi: 10.1155/2016/7983236. Epub 2016 Dec 14. Review.

Supplemental Content

Loading ...
Support Center